Key result
FHL1-related reducing body myopathy in females mimics inflammatory myopathy, causing ambulation loss in ~6 years.
Cohort
Yes
FHL1-related reducing body myopathy can present as a rapidly progressive muscle weakness mimicking inflammatory myopathy in female patients, highlighting the importance of muscle biopsy for accurate diagnosis.
Answers are grounded in this paper and cite their sources.
Consider FHL1-related myopathy in females with rapidly progressive weakness mimicking myositis; extends phenotypic spectrum and leaves open optimal diagnostic strategies.
Background and Objectives: gene. The disease is characterized by protein aggregates in myocytes strongly stained with menadione-nitro blue tetrazolium with α-glycerophosphate and immunoreactive for FHL1 as myopathologic hallmarks. RBM is an X-linked dominant disorder, with the most severe cases occurring in hemizygous sporadic male patients, who usually present with early onset and rapid progression. This study aimed to comprehensively analyse a cohort of FHL1 female patients presenting with a severe and rapidly progressive phenotype clinically mimicking an inflammatory idiopathic myopathy. Methods: gene from France and Italy. Data regarding clinical onset and progression, myopathologic features, muscle imaging, and genetic testing have been collected retrospectively and analyzed from medical records. Result: and loss of ambulation after a mean period of 6.2 years in 4 of them. Serum CK level at onset was slightly elevated with a mean value of 539 UI/L. Muscle MRI revealed severe asymmetric proximo-distal involvement with STIR positive sequences. Muscle biopsies showed reducing bodies and prominent autophagic material accumulation. Discussion: -related reducing body myopathy can present with a rapidly progressive muscle weakness mimicking an inflammatory myopathy also in female patient. Muscle biopsy is an useful tool in the contest of rapidly progressive myopathy to distinguish between genetic myopathies and treatable inflammatory myopathy.
No takes yet. Share an insight, caveat, or question.
Severa et al. (2026) conducted a cohort in Reducing Body Myopathy. FHL1-related reducing body myopathy in female patients can present with rapidly progressive muscle weakness mimicking inflammatory myopathy, leading to loss of ambulation after a mean of 6.2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: